Følg
Justin Guinney
Justin Guinney
Tempus
Verifisert e-postadresse på tempus.com
Tittel
Sitert av
Sitert av
År
GSVA: gene set variation analysis for microarray and RNA-seq data
S Hänzelmann, R Castelo, J Guinney
BMC bioinformatics 14 (1), 1-15, 2013
40142013
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
32992015
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
25262018
Genome-wide methylation profiles reveal quantitative views of human aging rates
G Hannum, J Guinney, L Zhao, LI Zhang, G Hughes, SV Sadda, B Klotzle, ...
Molecular cell 49 (2), 359-367, 2013
22372013
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium, AACR Project GENIE Consortium, ...
Cancer discovery 7 (8), 818-831, 2017
7272017
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
R Dienstmann, L Vermeulen, J Guinney, S Kopetz, S Tejpar, J Tabernero
Nature reviews cancer 17 (2), 79-92, 2017
7042017
F-Seq: a feature density estimator for high-throughput sequence tags
AP Boyle, J Guinney, GE Crawford, TS Furey
Bioinformatics 24 (21), 2537-2538, 2008
4162008
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes
FA Sinicrope, Q Shi, TC Smyrk, SN Thibodeau, R Dienstmann, J Guinney, ...
Gastroenterology 148 (1), 88-99, 2015
3102015
Evidence for type II cells as cells of origin of K-Ras–induced distal lung adenocarcinoma
X Xu, JR Rock, Y Lu, C Futtner, B Schwab, J Guinney, BLM Hogan, ...
Proceedings of the National Academy of Sciences 109 (13), 4910-4915, 2012
2782012
Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection
AD Ewing, KE Houlahan, Y Hu, K Ellrott, C Caloian, TN Yamaguchi, ...
Nature methods 12 (7), 623-630, 2015
2732015
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine
MW Kattan, KR Hess, MB Amin, Y Lu, KGM Moons, JE Gershenwald, ...
CA: a cancer journal for clinicians 66 (5), 370-374, 2016
2392016
Inferring causal molecular networks: empirical assessment through a community-based effort
SM Hill, LM Heiser, T Cokelaer, M Unger, NK Nesser, DE Carlin, Y Zhang, ...
Nature methods 13 (4), 310-318, 2016
2112016
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
2002020
Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data
IS Jang, EC Neto, J Guinney, SH Friend, AA Margolin
Biocomputing 2014, 63-74, 2014
1842014
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ...
Nature communications 10 (1), 1-17, 2019
1832019
The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment
MA Haendel, CG Chute, TD Bennett, DA Eichmann, J Guinney, WA Kibbe, ...
Journal of the American Medical Informatics Association 28 (3), 427-443, 2021
1822021
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ...
Annals of Oncology 28 (5), 1023-1031, 2017
1672017
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell DependenciesDrug Responses Among Consensus Molecular …
A Sveen, J Bruun, PW Eide, IA Eilertsen, L Ramirez, A Murumägi, ...
Clinical Cancer Research 24 (4), 794-806, 2018
1642018
Evaluation of combined artificial intelligence and radiologist assessment to interpret screening mammograms
T Schaffter, DSM Buist, CI Lee, Y Nikulin, D Ribli, Y Guan, W Lotter, Z Jie, ...
JAMA network open 3 (3), e200265-e200265, 2020
1592020
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
1532020
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20